Endogenous events modulating myogenic regulation of cerebrovascular function

Area of Science:

• Biochemistry
• Physiology
• Neuroscience

Background:

• Arterial myogenic tone, crucial for blood flow regulation, was described in 1902, but its link to pressure-dependent depolarization emerged in 1984.
• The specific factors mediating myogenic arterial constriction remained largely unknown.
• Cerebral arterial muscle cells express CYP 4A ω-hydroxylase, producing 20-hydroxyeicosatetraenoic acid (20-HETE) from arachidonic acid (AA), with production increasing under elevated pressure.

Purpose of the Study:

• To investigate the role of 20-hydroxyeicosatetraenoic acid (20-HETE) in cerebral myogenic tone and its implications in ischemic stroke.
• To explore the interplay between CYP enzymes, reactive oxygen species (ROS), and cerebrovascular function.
• To identify potential therapeutic targets for managing cerebral circulation disorders.

Main Methods:

• Analysis of CYP 4A ω-hydroxylase activity in cerebral arterial muscle cells.
• Investigating the effects of 20-HETE on protein kinase C (PKC), KCa channels, L-type Ca2+ channels, and intracellular calcium ([Ca2+]i).
• Examining the role of CYP epoxygenases, epoxyeicosatrienoic acids (EETs), and ROS in cerebral blood flow regulation and ischemic injury.

Main Results:

• 20-HETE, a potent vasoconstrictor, is produced by cerebral arterial muscle cells and its production increases with intravascular pressure.
• 20-HETE mediates cerebral autoregulation by activating PKC, inhibiting KCa channels, depolarizing membranes, activating L-type Ca2+ channels, and increasing intracellular calcium.
• Increased 20-HETE levels in ischemia/reperfusion injury stimulate ROS production, exacerbating ischemic stroke, an effect preventable by inhibiting 20-HETE.
• CYP epoxygenases produce vasodilatory EETs, which increase during ischemia and offer protection.
• ROS, generated by CYP enzymes and hypoxia, modify cerebral myogenic tone and cerebrovascular function.

Conclusions:

• The brain's capacity to produce 20-HETE and EETs via CYP enzymes, along with ROS generation, significantly influences cerebral blood flow dynamics.
• 20-HETE plays a critical role in mediating cerebral myogenic tone and is implicated in ischemic stroke pathogenesis.
• Inhibition of 20-HETE synthesis or action presents a promising therapeutic strategy for ischemic stroke and other cerebral circulation disorders.